Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APPN NASDAQ:AVDX NYSE:CXM NASDAQ:DH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPPNAppian$29.39+2.0%$30.61$24.00▼$43.33$2.18B1.72564,786 shs40,353 shsAVDXAvidXchange$9.86+0.1%$9.79$6.61▼$12.93$2.03B1.22.63 million shs86,896 shsCXMSprinklr$9.08+0.8%$8.48$6.75▼$9.93$2.35B0.82.06 million shs93,582 shsDHDefinitive Healthcare$3.95+2.8%$3.68$2.15▼$6.16$586.39M1.64807,891 shs10,670 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPPNAppian0.00%+0.42%+2.16%+11.54%-18.39%AVDXAvidXchange0.00%+0.20%+0.82%+32.21%-20.63%CXMSprinklr0.00%+5.26%+12.15%+30.62%-4.05%DHDefinitive Healthcare0.00%-2.04%+1.05%+52.99%-31.67%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPPNAppian4.075 of 5 stars4.11.00.03.01.43.30.6AVDXAvidXchange2.595 of 5 stars2.03.00.00.02.23.31.9CXMSprinklr3.6389 of 5 stars3.01.00.00.02.83.33.1DHDefinitive Healthcare2.6196 of 5 stars3.03.00.00.02.72.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPPNAppian 2.13Hold$36.2923.46% UpsideAVDXAvidXchange 1.94Reduce$10.304.52% UpsideCXMSprinklr 2.08Hold$10.2512.95% UpsideDHDefinitive Healthcare 1.90Reduce$5.1029.21% UpsideCurrent Analyst Ratings BreakdownLatest DH, APPN, CXM, and AVDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/27/2025CXMSprinklrJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$17.006/9/2025APPNAppianDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold6/5/2025CXMSprinklrMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$8.00 ➝ $10.006/5/2025CXMSprinklrDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$8.00 ➝ $9.006/5/2025CXMSprinklrJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$17.006/5/2025CXMSprinklrWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$6.00 ➝ $7.006/5/2025CXMSprinklrRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$12.006/3/2025CXMSprinklrCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$8.005/13/2025APPNAppianCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$40.00 ➝ $41.005/12/2025DHDefinitive HealthcareThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $3.405/9/2025APPNAppianMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$27.00 ➝ $29.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPPNAppian$617.02M3.54N/AN/A($0.44) per share-66.80AVDXAvidXchange$438.94M4.64$0.25 per share38.86$3.27 per share3.01CXMSprinklr$796.39M2.95$0.21 per share43.09$2.40 per share3.78DHDefinitive Healthcare$252.20M2.33$5.41 per share0.73$4.09 per share0.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPPNAppian-$92.26M-$0.83N/A163.28N/A-9.55%N/A-6.08%7/30/2025 (Estimated)AVDXAvidXchange$8.15MN/A985.0089.59N/A0.42%1.19%0.40%7/30/2025 (Estimated)CXMSprinklr$121.61M$0.4122.1869.811.9813.57%6.86%3.51%9/3/2025 (Estimated)DHDefinitive Healthcare-$413.12M-$4.39N/A28.196.46-206.05%3.69%2.15%8/4/2025 (Estimated)Latest DH, APPN, CXM, and AVDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025APPNAppian-$0.13N/AN/AN/A$160.01 millionN/A8/4/2025Q2 2025DHDefinitive Healthcare$0.05N/AN/AN/A$59.22 millionN/A7/30/2025Q2 2025AVDXAvidXchange$0.06N/AN/AN/A$110.18 millionN/A6/4/2025Q1 2026CXMSprinklr$0.10$0.12+$0.02-$0.01$201.83 million$205.50 million5/8/2025Q1 2025APPNAppian$0.03$0.13+$0.10-$0.02$163.27 million$166.43 million5/8/2025Q1 2025DHDefinitive Healthcare$0.02$0.05+$0.03-$0.95$56.20 million$59.19 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPPNAppianN/AN/AN/AN/AN/AAVDXAvidXchangeN/AN/AN/AN/AN/ACXMSprinklrN/AN/AN/AN/AN/ADHDefinitive HealthcareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPPNAppianN/A1.251.25AVDXAvidXchange0.101.321.32CXMSprinklrN/A1.741.74DHDefinitive Healthcare0.371.751.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPPNAppian52.70%AVDXAvidXchange80.58%CXMSprinklr40.19%DHDefinitive Healthcare98.67%Insider OwnershipCompanyInsider OwnershipAPPNAppian44.00%AVDXAvidXchange11.10%CXMSprinklr60.53%DHDefinitive Healthcare14.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPPNAppian2,03374.23 million41.57 millionOptionableAVDXAvidXchange1,600206.45 million183.53 millionOptionableCXMSprinklr3,589258.84 million102.16 millionNot OptionableDHDefinitive Healthcare970148.64 million126.58 millionNot OptionableDH, APPN, CXM, and AVDX HeadlinesRecent News About These CompaniesMassachusetts Financial Services Co. MA Has $9.07 Million Position in Definitive Healthcare Corp. (NASDAQ:DH)July 20 at 4:40 AM | marketbeat.com130,266 Shares in Definitive Healthcare Corp. (NASDAQ:DH) Bought by Teacher Retirement System of TexasJuly 18 at 3:14 AM | marketbeat.comDefinitive Healthcare (NASDAQ:DH) Trading Up 1.8% - Still a Buy?July 17, 2025 | marketbeat.comDefinitive Healthcare Corp. (NASDAQ:DH) Given Average Rating of "Reduce" by BrokeragesJuly 17, 2025 | americanbankingnews.comDefinitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of "Reduce" from BrokeragesJuly 17, 2025 | marketbeat.comDefinitive Healthcare (NASDAQ:DH) Shares Down 5.4% - Should You Sell?July 11, 2025 | marketbeat.comDefinitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)July 1, 2025 | globenewswire.comDH - Definitive Healthcare Corp Class A Dividends - MorningstarJune 28, 2025 | morningstar.comMDefinitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of "Reduce" by AnalystsJune 22, 2025 | marketbeat.comDefinitive Healthcare (NASDAQ:DH) Stock Rating Upgraded by Wall Street ZenJune 21, 2025 | marketbeat.comDefinitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating SticksJune 14, 2025 | seekingalpha.comDefinitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)June 3, 2025 | globenewswire.comEarnings Release: Here's Why Analysts Cut Their Definitive Healthcare Corp. (NASDAQ:DH) Price Target To US$4.06May 11, 2025 | finance.yahoo.comDefinitive Healthcare Corp. (DH) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comDefinitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025May 9, 2025 | taiwannews.com.twTDefinitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue EstimatesMay 8, 2025 | zacks.comDefinitive Healthcare Announces Timing of Its First Quarter 2025 Financial Results Conference Call and WebcastApril 24, 2025 | globenewswire.comWhy Definitive Healthcare Corp.’s (DH) Stock Is Down 8.78%April 10, 2025 | aaii.comADefinitive Healthcare reports inducement grants under Nasdaq listing ruleApril 5, 2025 | markets.businessinsider.comDefinitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)April 4, 2025 | gurufocus.comDefinitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)April 4, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesDo They Know Something? Insiders & Congress Buy UnitedHealthBy Brian O'Connell | July 9, 2025View Do They Know Something? Insiders & Congress Buy UnitedHealthSoundHound Rises as Short Sellers Exit and AI Demand GrowsBy Thomas Hughes | July 9, 2025View SoundHound Rises as Short Sellers Exit and AI Demand GrowsInsiders Spent Millions on These 3 Stocks Over the Past 2 MonthsBy Leo Miller | July 17, 2025View Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Summer Short-Squeeze Candidates With Catalysts for CoveringBy Thomas Hughes | June 30, 2025View 3 Summer Short-Squeeze Candidates With Catalysts for CoveringHow Texas Roadhouse Is Winning in a Changing Consumer MarketBy Dan Schmidt | July 14, 2025View How Texas Roadhouse Is Winning in a Changing Consumer MarketDH, APPN, CXM, and AVDX Company DescriptionsAppian NASDAQ:APPN$29.39 +0.58 (+2.02%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Appian Corporation, a software company that provides low-code design platform in the United States, Mexico, Portugal, and internationally. The company's platform offers artificial intelligence, process automation, data fabric, and process mining. It provides The Appian Platform, an integrated automation platform that enables organizations to design, automate, and optimize mission-critical business processes. The company also offers professional and customer support services. It serves to financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. Appian Corporation was incorporated in 1999 and is headquartered in McLean, Virginia.AvidXchange NASDAQ:AVDX$9.86 +0.01 (+0.05%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.AvidXchange Holdings, Inc. provides accounts payable (AP) automation software and payment solutions for middle market businesses and their suppliers in North America. The company offers AP automation software, a SaaS-based solution that automates and digitizes capture, review, approval, and payment of invoices for buyers; the AvidPay network that connects two-sided payments with buyers and suppliers; and the AvidXchange Supplier Hub, which provides supplier insights to cash flow, tools for in-network invoices and payments, and early payment feature. Its platform offers electronic invoice capture, workflow routing, and automated payments solutions. The company serves real estate, community association management, construction, financial services, healthcare facilities, social services, education, hospitality, and media sectors through direct salesforces; strategic channel partnerships; and software and technology business partners. AvidXchange Holdings, Inc. was incorporated in 2000 and is headquartered in Charlotte, North Carolina.Sprinklr NYSE:CXM$9.07 +0.08 (+0.83%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Sprinklr, Inc. provides enterprise cloud software products worldwide. The company operates Unified Customer Experience Management platform, a software that enables customer-facing teams to collaborate across internal silos, communicate across digital channels, and leverage a complete suite of capabilities to deliver customer experiences. Its products include Sprinklr Service, a suite of artificial intelligence (AI) powered products and solutions that unifies customer service across voice, digital, and social channels; Sprinklr Social, a suite of AI-powered products and solutions that unifies social media publishing and engagement across various channels; Sprinklr Insights, a suite of AI-powered products and solutions that unifies consumer, customer, competitive and industry data from a high volume of third-party, second-party and first-party sources; and Sprinklr Marketing, a suite of AI-powered products and solutions that unifies content production and content lifecycle management with paid campaign orchestration across various channels. The company also provides professional, managed, training, and consultancy services. Sprinklr, Inc. was founded in 2009 and is headquartered in New York, New York.Definitive Healthcare NASDAQ:DH$3.95 +0.11 (+2.79%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
